Vitamin C Supplementation for Gut Health in Adults with Obesity

This study is looking at whether taking a Vitamin C supplement can improve gut health and reduce inflammation in adults with obesity. Researchers believe that better vitamin C levels might help prevent "leaky gut," where harmful substances can enter the bloodstream and cause inflammation. You would receive either a Vitamin C supplement (1000 mg/d) or a placebo while following a low vitamin C diet for two separate two-week periods. The main goal is to see if Vitamin C can improve how well your small intestine acts as a barrier. This study is for English-speaking men and women aged 18-50 with a BMI between 30-40 kg/m².

Study design
This is a randomized, double-blind, placebo-controlled crossover study with 34 participants. This means participants are randomly assigned to groups, neither you nor the researchers will know if you're getting the Vitamin C or placebo, and you will try both the Vitamin C and placebo at different times.
What's involved
You would complete two study periods, each lasting two weeks, with a two-week break in between. During these periods, you will follow a low vitamin C diet, track your diet and activity, and provide blood, urine, and stool samples. You will also have a test to measure gut permeability.
Compensation
Not stated in the trial record.
Follow-up
The primary endpoint for measuring small intestinal permeability is at day 14 following each 2-week intervention period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07151105

Anti-inflammatory Activities of Vitamin C Supplementation on the Gut Barrier Function in Adults With Obesity

Recruiting
NAAges 18–50InterventionalBasic science
Ohio State University
~34 participants
Updated 2026-09-01 on ClinicalTrials.gov
What's tested:Vitamin C Supplement + Low Vitamin C DietPlacebo + Low Vitamin C Diet

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Small Intestinal Permeability
Measured over Between-treatment arm comparison on day 14 following 2-week intervention.
Adequate Vitamin C Status
Inadequate Vitamin C Status
1 sites across 1 states
Ohio1
  • Richard Bruno, PhD, RD · PRINCIPAL_INVESTIGATOR · Ohio State University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

English speaking
Men and women between 18-50 years of age
BMI 30-40 kg/m²
Resting blood pressure \<140/90 mm Hg
No use of multivitamin/vitamin C supplement within past 1-month
Non-vegetarian/non-vegan
Willingness to follow a diet low in fruits and vegetables for two, 2-week periods

Exclusion

Current smoker or vaper, including tobacco, cannabis, or nicotine products
Alcohol consumption \>2 drinks/day
Use of antibiotics within past 1-month
Use of probiotic supplements within past 1-month
Use of anti-inflammatory drugs within past 1-month
Individuals with unmanaged or poorly controlled diabetes, dyslipidemia, hypertension
Known history of bleeding disorders, hemochromatosis, or kidney stones
For Women: Pregnancy, lactation, or change in birth control within the past 3-months
Use of certain medications that may interact with vitamin C, including blood thinners, some antiviral drugs (e.g., indinavir), and certain antipsychotic medications (e.g., fluphenazine).
  • Small Intestinal PermeabilityBetween-treatment arm comparison on day 14 following 2-week intervention.

    Urinary excretion ratio of lactulose/mannitol following oral ingestion of these sugar probes.